This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Eating patterns can override genetic risk for type 2 diabetes. Discover the 4 dietary approaches proving most effective at ...